
    
      This is a feasibility level study conducted to assess the recovery and survival of
      autologous, radiolabeled leukoreduced packed red blood cells (LR-pRBC) derived from fresh
      whole blood (WB) units that have been treated with the Mirasol System for Whole Blood
      (Mirasol System) and stored for 21 days at 1-6Â°C.1
    
  